Recent experimental evidence suggests that arterial insufficiency precedes the structural and functional changes in corpora cavernosa (CC) leading to organic erectile dysfunction (ED). The present review gives an overview of the physiological factors involved in the regulation of penile vasculature. Sympathetic nerves maintain flaccidity and tonically released noradrenaline induces vasoconstriction of both arteries and veins through a 1 -and a 2 -postsynaptic receptors and downregulates its own release and that of nitric oxide (NO) through a 2 -presynaptic receptors. The sympathetic cotransmitter neuropeptide Y (NPY) modulates noradrenergic vasoconstriction in penile small arteries by both enhancing and depressing noradrenaline contractions through Y 1 -and Y 2 -postsynaptic and a NO-independent atypical endothelial receptor, respectively. Activation of a 1 -adrenoceptors involves both Ca 2 þ influx through L-type and receptor-operated Ca 2 þ channels (ROC) and Ca 2 þ sensitization mechanisms mediated by protein kinase C (PKC), tyrosine kinases (TKs) and Rho kinase (RhoK). In addition, RhoK can regulate Ca 2 þ entry in penile arteries upon receptor stimulation. Vasodilatation of penile arteries and large veins during erection is mediated by neurally released NO. The subsequent increased arterial inflow to the cavernosal sinoids and shear stress on the endothelium lining penile arteries activates endothelial NO production through Akt phosphorylation of endothelial NO synthase (eNOS). NO stimulates guanylate cyclase and increased cyclic guanin 3 0 -monophosphate (cGMP) levels in turn activate protein kinase G (PKG), which enhances K þ efflux through Ca 2 þ -activated (K Ca ) and voltage-dependent Ca 2 þ (K v ) channels in penile arteries and veins, respectively. PKG-mediated decrease in Ca 2 þ sensitivity and its regulation by RhoK remains to be clarified in penile vasculature. Phosphodiesterase type 5 (PDE5) inhibitors are potent vasodilators of penile resistance arteries and increase the content and effects of basally released endothelial NO. Endothelium-dependent relaxations of penile small arteries also include an endothelium-derived hyperpolarizing factor (EDHF)-type response, which is impaired in diabetes and hypertension-associated ED. Locally produced contractile and relaxant prostanoids regulate penile venous and arterial tone, respectively. The latter activates prostaglandin I (IP) and prostaglandin E (EP) receptors coupled to adenylate cyclase and to the increase of cyclic adenosine monophosphate (cAMP) levels, which in turn stimulates K þ efflux through ATPsensitive K þ (K ATP ) channels. There is a crosstalk between the cGMP and cAMP signaling pathways in penile small arteries. Relevant issues such as the mechanisms underlying the excitationsecretion coupling of the endothelial cells, as well as those involved in cell proliferation and vascular remodeling of the penile vasculature remain to be elucidated. In addition, only few studies have investigated the changes in structure and function of penile arteries in cardiovascular risk situations leading to ED.
Introduction
Erectile dysfunction (ED) is a condition defined by the inability to reach or maintain a penile erection sufficient for satisfactory sexual performance. 1 Its high prevalence in patients with cardiovascular risk factors and in conjunction with vascular abnormalities such as coronary artery disease, hypertension, cerebrovascular accidents and peripheral arterial disease has led to the suggestion that ED is another manifestation of vascular disease 2, 3 and indicates that impairment of the vasoconstrictor/vasodilator processes in the penis underlie the pathogenesis of ED. Penile erection occurs when activation of parasympathetic nerves and release of nitric oxide (NO) from nerve terminals and endothelium upon sexual stimulation decreases vascular resistance and increases blood flow through cavernous and helicine arteries. This allows the filling of the sinoids, the rise in intracavernosal pressure (ICP) and the restriction of venous outflow by compression of subtunical veins against the tunica albuginea with entrapment of pressurized blood in the corpora cavernosa, which is referred to as veno-occlusive mechanism.
4 ED can be considered as a threefold process where arterial insufficiency is followed by inability to obtain tumescence due to defective filling of the corpum cavernosum (CC) and faulty veno-occlusion, although initial alterations in CC and primary venous leak can also be the cause of ED. 5 The main arterial supply to the penis is via the internal pudendal artery that branches off the hypogastric artery and splits into bulbourethral, dorsal and cavernosal arteries. 4, 6 While the bulbourethral artery supplies the urethra and the glans, the cavernous arteries penetrate the tunica albuginea and enter the corpora cavernosa to give rise to multiple tortuous branches, the helicine arteries that open directly into and feed the cavernous spaces, acting as resistance arteries. 7 The paired dorsal penile arteries supply superficial structures in the penis and also the CCs via circumflex arteries along the shaft of the penis as a normal variant. 4, 6 There are three groups of veins draining the penis: superficial, intermediate and deep. 4, 6, 8 The superficial system primarily drains penile skin, although it can have anastomotic connections to the deep dorsal vein. The intermediate venous system consists of deep dorsal and circumflex veins. The trabeculae of the CC drain into a system of subtunical venules that coalesce just beneath the tunica albuginea and form a number of veins transversing the tunica called emissary veins, which usually drain into the circumflex veins on the outer surface of the tunica albuginea. The circumflex veins in turn drain into the deep dorsal vein of the penis shaft between the dorsal arteries. The deep venous system drains the deep cavernous tissue and consists of cavernosal and crural veins that are extensions of the emissary veins.
Compression and elongation of the subtunical venules contribute to penile veno-occlusion and is thought to be the mechanism responsible for the generation of the increased outflow resistance during erection. 9, 10 In addition to this mechanical restriction of the venous outflow, there is an active regulation of venous resistance, and several vasoconstrictor and vasodilator stimuli can regulate penile venous tone to the same extent as arterial and cavernous smooth muscle. [11] [12] [13] [14] [15] [16] [17] The active control of penile veins probably accommodates blood flow from the penis to the hemodynamic changes that take place in the CC during erection and detumescence.
Penile erection and flaccidity are ultimately regulated by the relaxation and contraction, respectively, of arterial and trabecular smooth muscle, and a metabolic imbalance between contractile and relaxant factors in the CC, penile arteries and veins is one of the main causes of organic ED. 18 Basic science research on ED has been devoted to investigating the mechanisms underlying relaxation of CC, but during the last decade, this research has been extended to the arterial smooth muscle, in particular that of penile resistance arteries or helicine arteries, which act as sphincters and regulate blood flow between the systemic circulation and the cavernous sinoids. 6, 7 Since recent evidence demonstrates that arterial insufficiency precedes the structural and functional changes in CC leading to ED, 6, 19 the present review focuses on the physiological factors involved in the regulation of penile vasculature, its role in penile erection and detumescence, and its relevance for the pathogenesis of ED.
Physiological regulation of penile vasoconstriction
Neural control of vasoconstriction Penile smooth muscle receives a rich sympathetic innervation, and adrenergic nerves are responsible for the detumescence of the erect penis and also contribute to the maintenance of the flaccid state through the tonic release of noradrenaline. 20 Adrenergic stimuli cause contraction of corporal smooth muscle and arterial vasoconstriction, which leads to the reduction of arterial inflow and to the collapse of the lacunar spaces, respectively, allowing decompression of subtunical venules and venous drainage of the corpora. 4, 21 In vitro experiments have shown that transmural stimulation of periarterial nerves evokes vasoconstriction of the isolated cavernous artery through a mixed population of postjunctional a 1 -and a 2 -adrenoceptors, 22 while in horse penile resistance arteries, only a 1 -adrenoceptors appear to be involved in the contractions evoked by both neural-released and exogenous-added noradrenaline. 23 Noradrenaline downregulates its own release from adrenergic nerves acting on inhibitory prejunctional a 2 -adrenoceptors in intracavernous arteries 23 ( Figure 1 ). There is also evidence for an adrenergic regulation of penile veins, and adrenergic stimuli induce venoconstriction through a heterogeneous population of a 1 -and a 2 -postjunctional adrenoceptors in both circumflex 11 and deep dorsal veins. 24 In the Physiological regulation of penile arteries and veins D Prieto latter, noradrenergic nerve terminals penetrate deep in the smooth muscle effector layer which suggests a mechanism to respond faster and more extensively to the vasoconstrictor nerve activity, 24 thus reinforcing the concept of an active regulation of penile venous tone during detumescence.
Adrenergic transmitters can also induce vasodilatation in penile arteries through b-adrenoceptors. Injection of b 2 -adrenoceptor agonists produces erection in cats, 4 and functional studies have demonstrated the presence of the b 2 -subtype in isolated horse penile resistance arteries, 23 adrenaline being a very potent agonist at this receptor. Since plasma levels of adrenaline increase during erection, b-adrenoceptors have been suggested to further increase arterial inflow in connection with sexual intercourse-associated metabolism and physical activity. 6 Activation of sympathetic nerves still has antierectile effects under conditions of a-adrenoceptor blockade, suggesting that neurotransmitters other than noradrenaline may contribute to the vasoconstrictor sympathetic activity in the penis. 20 Neuropeptide Y (NPY), a 36-amino acid peptide usually colocalized with noradrenaline in sympathetic perivascular nerves, is widely distributed in penile erectile tissues with a particularly high density around helicine arteries. 12, 25, 26 Although NPY was initially suggested to have a role in detumescence, 20 earlier in vitro studies showed either no effect of NPY in strips of human CC and cavernous artery or inconsistent contractions in penile circumflex veins. 4, 12 Moreover, intracavernous injection of NPY increased intracavernous pressure and caused penile tumescence in rabbits. 27 We have recently provided an explanation for this controversy between the rich presence of NPY-containing nerves in the penis and the lack of clear antierectile/vasoconstrictor effects of the peptide. 26 Thus, NPY was found to have a dual facilitatory/inhibitory role on the noradrenergic vasoconstriction of horse penile resistance arteries, the ability to enhance and decrease noradrenaline-induced contractions being achieved through a heterogenous population of NPY receptors. Both Y 1 -and Y 2 -postsynaptic receptors are involved in the NPY-induced enhancement of noradrenaline contractions, and presynaptic inhibitory Y 2 receptors limit noradrenaline release from (Figure 1 ). The Y 1 receptor is a G-protein-coupled receptor that usually enhances other constrictors responses in small arteries by depolarizing arterial smooth muscle and by inhibiting cyclic adenosine monophosphate (cAMP)-mediated relaxations. 28, 29 Under conditions of Y 1 and Y 2 receptor blockade, NPY can also induce NO-independent relaxations in penile resistance arteries through atypical receptors located at the endothelium, which could account for the in vivo proerectogenic effects reported for the peptide. 26 
Contractile prostanoids
Penile erectile tissues synthesize and locally metabolize several contractile prostanoids. Thus, both a basal release and an acetylcholine (ACh)-stimulated production of PGF 2a , thromboxane A 2 (TXA 2 ) and PGE 2 modulated by O 2 tension and reduced by hypoxia 30 have been demonstrated in rabbit CC. 31 In the trabecular tissue, basal prostanoid production is involved in the maintenance of the myogenic spontaneous tone consisting of phasic and tonic contractions. 32 Agonist-induced endothelial stimulation of both human and rabbit CC and horse deep dorsal penile vein evokes the release of contractile prostanoids. 17, 31, 32 In the latter, blockade of NO synthase (NOS) unmasks a prostanoid-mediated endothelium-dependent contraction to ACh through muscarinic M 1 receptors. 17 The main receptor involved in the contractile effect of prostanoids in the human penis belongs to the TP type in both trabecular smooth muscle and resistance arteries. 33, 34 Angiotensin II In the penis, angiotensin II (AII) is locally formed in the endothelium and smooth muscle of the CC, 35 where it has contractile effects mediated by muscular AT 1 receptors. 36, 37 AII levels in the cavernous blood are increased during detumescence 37 and AT 1 receptor antagonists reduce the contractions evoked by electrical field simulation (EFS) in CC in vitro 38 and increase intracavernous pressure in vivo. 35 This has led to the suggestion that AII might be involved in the initiation of detumescence as a consequence of enhanced sympathetic activity. The functional role of AII in penile arteries and veins remains to be established, but the protective effect of AT 1 receptor antagonists on the structural changes of penile blood vessels in arterial hypertension suggests that besides vasoconstriction, AII plays a role in vascular remodeling induced by high blood pressure. 39 Endothelins Endothelins (ETs) are potent vasoconstrictor peptides synthesized by endothelial cells that have been reported to induce both contraction and ET Bmediated relaxation of erectile tissues. 40, 41 ET A and ET B receptors subtypes are located at penile smooth muscle and nerves, respectively, 40 and infusion of ET-1 and ET-3 in the rat increases ICP at low doses, and produces vasoconstriction followed by decrease in pressure at high concentrations. 42 ET A and ET B receptors are also involved in cell proliferation and gene expression of human-cultured corporal myocytes, 43 but this role in the penile vasculature remains to be clarified.
Intracellular signaling pathways underlying penile vasoconstriction
is considered a classic trigger for force development in smooth muscle through activation of myosin light-chain kinase and subsequent phosphorylation of the myosin light chain (MLC). However, smooth muscle contraction can also be modulated through inhibition of MLC phosphatase (MLCP) by Ca 2 þ -independent mechanisms resulting in an increased MLC phosphorylation and force at constant [Ca 2 þ ] i , which is referred to as Ca 2 þ sensitization. 44 Agonists binding G-protein-coupled receptors usually stimulate both Ca 2 þ mobilization from intracellular stores 45 and Ca 2 þ entry through both dihydropyridine-sensitive L-type and non-L-type Ca 2 þ channels. 46 Recent investigations carried out by our group have elucidated the Ca 2 þ handling mechanisms in penile arterial smooth muscle, so far poorly understood. Thus, a 1 -adrenoceptor-and TP receptormediated contractions are largely dependent on Ca 2 þ entry through both voltage-dependent L-type and receptor-operated Ca 2 þ channels (ROCs) in rat penile dorsal arteries. 47 There is a minor role for either intracellular Ca 2 þ mobilization or storeoperated Ca 2 þ (SOC) entry, in contrast to that reported for rat and human CC, where a significant contribution of Ca 2 þ from intracellular stores to phenylephrine-induced contractions has been reported. 48 However, a capacitative Ca 2 þ entry through SOCs not coupled to contraction but probably related to non-contractile functions of vascular smooth muscle cells, such as protein and gene expression, 49 is present in penile small arteries. Despite the large extracellular Ca 2 þ dependence of penile vasoconstriction, there are also potent mechanisms of Ca 2 þ sensitization of the contractile proteins involving several kinases such as protein kinase C (PKC), tyrosine kinases (TKs) and Rho kinase (RhoK), 47 which suggests that Ca 2 þ entry and Ca 2 þ sensitization may cooperate to elicit vasoconstriction upon a 1 -adrenergic receptor stimulation. RhoA is a member of the Ras superfamily of small GTP-binding proteins and RhoK is a serinethreonine kinase which is activated by RhoA. 44 Tonic physiological activity of Rho/RhoK seems to play a key role in the regulation of erectile function and the maintenance of penile flaccidity. Thus, inhibition of RhoK in a rat in vivo model markedly 51 In human CC, RhoA-mediated Ca 2 þ sensitization contributes to smooth muscle contraction and flaccidity. 52 Interestingly, we have recently shown that RhoK is involved not only in the Ca 2 þ sensitization of the contractile apparatus but also in the regulation of Ca 2 þ entry through ROC channels upon a 1 -adrenoceptor activation in rat penile small arteries. 53 These findings suggest that RhoK and other kinases involved in Ca 2 þ homeostasis of penile arteries represent potential therapeutic targets for the treatment of organic ED (Figure 1 ).
Physiological regulation of penile vasodilatation
Neural control of vasodilatation Penile erection is initiated by activation of parasympathetic nerves upon sexual stimulation leading to vasodilatation of cavernous and helicine arteries and to the relaxation of trabecular smooth muscle. Despite the fact that ACh relaxes arterial and trabecular smooth muscle of the penis, earlier physiological studies carried out in several animal species and man showed that erection induced by activation of pelvic or cavernous nerves was atropine-resistant. 4 It is now well established that NO is the main chemical mediator of the vasodilatation and trabecular relaxation that lead to penile erection, and both nerves and endothelium are the source of NO locally released during this physiological event. ACh released from cholinergic nerves probably acts on prejunctional muscarinic receptors at sympathetic nerve terminals to inhibit noradrenaline release thereby decreasing sympathetic adrenergic tone, as reported for human CC. 8 NO is a free radical formed along with L-citrulline from L-arginine and molecular O 2 by the catalytic action of the enzyme NOS. 54 There are two constitutive NOS isoforms, neuronal NOS (nNOS) and endothelial NOS (eNOS), that require Ca 2 þ and calmodulin for activity, and one inducible isoform (iNOS), that is Ca 2 þ -and calmodulin-independent and is expressed in response to inflammatory mediators. 54 nNOS and eNOS are the principal isoforms involved in penile erection and are present in the nerves and endothelium of the penis, respectively. [55] [56] [57] nNOS has been found in the pelvic plexus and in terminal branches of the cavernous nerves innervating the trabecular smooth muscle and penile vasculature. 55, 58 nNOS and vesicular ACh transporter (VAChT) are co-localized in most nerve terminals surrounding penile small arteries which suggests that ACh and NO coexist in the same parasympathetic cholinergic neurons that control penile arterial tone. 56, 57 Earlier in vivo studies demonstrated that infusion of NOS inhibitors antagonized penile erection induced by pelvic stimulation and the nonadrenergic non-cholinergic (NANC) neurotransmitter mediating relaxation of the trabecular smooth muscle was later shown to be neural-released NO. 4 In our laboratory, we first provided functional evidence for the involvement of NO in the NANC inhibitory neurotransmission of equine and human penile resistance arteries. Thus, the NANC relaxations elicited by EFS were endothelium-independent, inhibited by the L-arginine analogue, N G -nitro-Larginine, by the NO scavenger, oxyhemoglobin, and by inhibitors of guanylate cyclase. 59, 60 Moreover, exogenous NO and nitrosothiols mimicked the vasodilatation induced by EFS, 59 -61 which suggests that NO or a NO-like substance released from nitrergic nerves mediates the neurogenic relaxations of penile resistance arteries.
Numerous NOS nerve fibers and a marked NOmediated neurogenic vasodilatation similar to that of penile arteries has also been reported for the human deep dorsal vein, 14, 58 which probably allows the vessel to accommodate the expansion of the CCs during erection. In contrast, no nitrergic relaxation was found in human circumflex veins, 62 which is consistent with the scarcity of NOS fibers 58 and suggests that a passive compression by engorgement of cavernous spaces rather than active neurogenic mechanisms is responsible for variations of venous outflow in the smaller penile veins. 14, 62 The contribution of the different isoforms of NOS to penile erection has been a subject of debate, specially because erectile function and mating behavior are preserved in mice lacking the genes for eNOS and nNOS. 63, 64 This was initially ascribed to a compensatory upregulation of eNOS to compensate for insufficient nNOS expression in mice lacking nNOS. 63 A later explanation for these intact NO-dependent erectile responses was the existence of nNOS gene variants resulting from alternative mRNA splicing of the bnNOS and gNOS alternative translation in exon 1. 65 By using nNOS, eNOS and doubly mutant-deficient mice, the alternatively spliced variant bnNOS has recently been confirmed as a major mediator in penile erection. 66 The activity of nNOS in the penile vasculature and CC is modulated by several factors such as neurotransmitters, hormones, autacoids and O 2 tension. Noradrenaline downregulates NO release through a 2 -adrenoceptors in penile resistance arteries. 67 There is a rich presence of peptidergic nerves containing vasoactive intestinal peptide (VIP) in the penis and nNOS, VIP and VAChT are co-localized in the same perivascular nerve terminals around penile arteries and in trabecular smooth muscle. 56, 57 VIP induces potent relaxations in penile arteries and veins. 4, 68 However, VIP antagonists do not inhibit neurogenic relaxations in penile small arteries, but VIP relaxant responses Physiological regulation of penile arteries and veins D Prieto are partially blocked by NOS inhibition, which suggests that VIP may have a presynaptic facilitatory role in the nitregic neurotransmission. 68 The role of androgens in erectile function is complex, although they seem to be involved in both central and peripheral neurotransmission including the modulation of NO synthesis. Castration impairs erectile responses and NOS activity in the penis of adult rats and androgen administration restores these changes, although it is a matter of debate whether they affect the expression of nNOS protein and mRNA. 6, 8, 69 The specific role of androgens in penile vasculature remains to be clarified. The expression and activity of NOS can also be regulated by autacoids such as prostaglandins and PGE 1 exerts a long-term upregulation of NO synthesis by increasing the penile content of both nNOS and eNOS after repeat treatment. 70 Since molecular O 2 is a substrate for the synthesis of both neural and endothelial NO by NOS, partial O 2 pressure (pO 2 ) in the blood of the CC plays a key role in the regulation of penile hemodynamics. During the flaccid state, pO 2 is similar to that of venous blood and it rises to 90-100 mm Hg during erection as a result of the increased arterial inflow to the sinuses. 71 pO 2 regulates the ability of CC smooth muscle to relax in response to EFS of the nerves and endothelium-dependent vasodilators such as ACh, these NO-dependent responses being progressively inhibited as a function decreasing pO 2 levels. 71 On the other hand, in a rabbit model of atherosclerosisinduced chronic cavernosal ischemia, both nNOS and eNOS proteins dramatically decrease in the erectile tissue which suggests that arterial insufficiency and subsequent exposure of erectile tissue to hypoxia impairs NOS expression and thus NO synthesis and relaxation. 72 This probably underlies arteriogenic ED induced by atherosclerosis and other arterial occlusive diseases.
Prostanoids
Relaxant prostanoids may be synthesized by both smooth muscle and endothelial cells and PGE 1 and PGE 2 being primarily produced in penile smooth muscle and PGI 2 in the vascular endothelium. 32, 73 A basal release of relaxant prostanoids is involved in the maintenance of penile arteriolar tone in horse 61 and human penile resistance arteries, 34 as depicted by the pronounced increase in basal tension and the inhibition of the arachidonic acid-elicited relaxations, respectively, produced by cyclooxygenase blockade. The involvement of relaxant prostaglandins in the endothelium-dependent vasodilatations of penile arteries and veins seems to be speciesdependent, and thus whereas in horse and human penile arteries and veins, cyclooxygenase blockade does not affect ACh-and histamine endotheliumdependent responses, 61, 74 it inhibits ACh-induced relaxations in bovine small arteries. 68 Since PGE 1 is the most efficacious drug used in the intracavernous treatment of ED, its relaxant effects are well characterized in both arterial and trabecular smooth muscle of the penis. Thus, PGE 1 evokes endothelium-and NO-independent relaxations mediated by cAMP in horse penile resistance arteries. 75, 76 This relaxant effect of PGE 1 in human penile arteries is correlated with its clinical effectiveness when injected intracavernously in patients. 77 The vasodilator effects of PGI 2 and PGE 1 are mediated by prostaglandin I (IP) and prostaglandin E (EP) (EP 2 / EP 4 ) receptors coupled to G proteins and to the activation of adenylate cyclase in human penile arteries. 34 In addition to its direct relaxant effect on smooth muscle, PGE 1 and PGE 2 can suppress collagen synthesis induced by transforming growth factor-b 1 (TGF-b 1 ) in the CC, thus regulating fibrosis in an O 2 -dependent manner. 73, 78 Increased fibrosis is correlated with venous leakage and failure of the veno-occlusive mechanism, thus leading to ED. 79 Therefore, arterial insufficiency, decreased pO 2 and increased fibrosis play a role in the pathogenesis of ED. 6, 73, 78 Endothelial regulation of penile arteries and veins As mentioned above, the high prevalence of ED in patients with cardiovascular diseases along with the fact that endothelial dysfunction and reduced availability of NO often underlie vascular diseases, such as hypertension, hypercholesterolemia and diabetes mellitus, suggests the essential role of the vascular endothelium in the physiology of penile erection, as well as its importance in the pathogenesis of ED. 2, 3, 80 Endothelial cells, located at the interphase between blood and the vascular wall, play a key role in the regulation of the underlying vascular tone and homeostasis and have the ability to synthesize shortlife vasoactive mediators such as NO, endotheliumderived hyperpolarizing factor (EDHF), PGI 2 , AII and ETs. 81 eNOS is present in the endothelium lining the cavernous sinoids and penile blood vessels, [55] [56] [57] 59 and endothelial-derived NO is produced in the penis by activation of eNOS in response to (1) hemodynamic stimuli like shear stress and pulsatile stretch generated by increased blood flow; (2) neurohumoral factors such as ACh, bradykinin and histamine acting on specific endothelial receptors. 6, 17, 61, 81 Endothelial receptor activation and shear-stress evoke transient and sustained increases in [Ca 2 þ ] i , respectively, which in turn induce transient and sustained activation of eNOS and NO production. NO is basally released from the arterial endothelium, as shown by the increase in spontaneous myogenic tone after blockade of NOS in human and equine penile small arteries. 60, 61 However, the involvement of endothelial NO in the agonist-induced vasodilations of the erectile tissues is variable, being more relevant in CC 17, 31, 60, 82 than in the small penile resistance arteries, where a non-NO non-prostanoid factor is a major component of the endothelium-dependent relaxant responses. 60, 61, 83, 84 Clinical investigations have recently demonstrated a flow-dependent vasodilatation in penile arteries by measuring the changes in the cavernous artery diameter after 5 min occlusion of penile flow. 85 These studies showed that flow-induced vasodilatation is strongly impaired in patients with organic ED and proposed this measurement as a clinical test to evaluate penile endothelial function. Increased flow-and shear stress-induced vasodilatation is inhibited by blockade of NOS and endothelial cell removal in human small arteries both in vivo and in vitro, this phenomenon being blunted in the microvasculature of hypertensive patients because of reduced NOS activity. 86, 87 However, the involvement of NO in the flow-dependent dilatation of penile arteries awaits further confirmation, although recent studies have elucidated the link between increased blood flow to the penis and eNOS activity, thus also clarifying the physiological interaction between endothelial and nerve-derived NO during penile erection. The study by Hurt et al. 88 showed that erection elicited by cavernosal nerve stimulation is mediated by phosphatidylinositol 3-kinase and activation of the protein kinase Akt. This pathway phosphorylates eNOS thereby increasing endothelial-derived NO 89 and is responsible for sustained NO production and the maintenance of maximal erection. 88, 90 Thus, neural NO-mediated vasodilatation and increased blood flow to the CC produced by parasympathetic activation during the initiation of erection leads to shear stress-mediated stimulation of the endothelial lining in penile arteries, which in turn releases NO from the endothelium and produces further vasodilatation and sustained erection (Figure 2) .
The activity of the constitutive eNOS is regulated predominantly at the post-translational level. The subcellular location of eNOS, its interaction with the protein caveolin-1 and the phosphorylation state of serine and threonine residues of the enzyme play a role in the post-translational regulation of eNOS. 88, 90 Thus, RhoK negatively regulates phosphorylation of eNOS at Ser1177 through inhibition of protein kinase Akt and downregulates eNOS expression in an Akt-independent fashion, thus inhibiting the production of endothelial NO. Figure 2 Physiological regulation of penile vasodilatation and erection. Nitric oxide (NO is released from parasympathetic nerve terminals upon sexual stimulation and diffuses into adjacent smooth muscle to activate guanylate cyclase (GC). Increased cGMP levels activate protein kinase G (PKG), which can either stimulate Ca 2 þ -activated K þ channels (K Ca ) and reduce intracellular Ca 2 þ , or phosphorylate myosin light-chain phosphatase (MLCP) and reduce Ca 2 þ sensitivity. PKG can phosphorylate Rho kinase (RhoK) and thus reduce its activity. Relaxation induced by neural NO increases blood flow and shear stress on the endothelial cells thereby increasing Akt phosphorylation of eNOS and NO production, and also releasing prostanoids and endothelium-derived hyperpolarizing factor (EDHF). Nerve-derived acetylcholine (ACh) can either limit noradrenaline (NA) release from sympathetic nerves through M 2 receptors or stimulate endothelial M 3 receptors to induce NO, EDHF and prostanoids release. Prostanoids activate IP/EP receptors coupled to adenylate cyclase (AC) and increased cAMP activates protein kinase A (PKA) and ATP-sensitive K þ (K ATP ) channels. COX, cyclooxygenase; CP450, cytochrome P450; EC, endothelial cells; IP/EP, prostaglandin I and prostaglandin I; NT, nerve terminal; PDE, phosphodiesterase; PGI 2 , prostacyclin; PLC, phospholipase C; SMC, smooth muscle cell.
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Rho/RhoK regulates erectile function in vivo in part by reducing activity of eNOS and the content of smooth muscle cyclic guanin 3 0 -monophosphate (cGMP) in the CC and upregulation of RhoK activity seems to be one of the causes of the reduced endothelial NO formation in the penis of type I diabetic rats. 92 
EDHF
In contrast to the CC, where the endotheliumdependent vasodilatation evoked by ACh is nearly abolished by blockade of NOS, in penile small arteries there is still a significant NOS-and cyclooxygenase-resistant relaxation evoked by endothelium-dependent agonists. 60, 61, 83 This non-NO non-prostanoid endothelial factor was first reported in systemic arteries and associated with cyclic nucleotide-independent hyperpolarization of arterial smooth muscle thereby being referred to as EDHF. 93 In the systemic circulation, there is a correlation between vessel size and the relative contribution of NO to the endothelium-dependent vasodilatations, the smaller the artery, the larger the component of the relaxation resistant to NOS blockade. This can also be applied to both penile arteries and veins. Thus, inhibition of NOS hardly affects the relaxation elicited by ACh in human, horse and bovine penile small arteries 60, 61, 83 and human penile circumflex veins, 62 but nearly abolished relaxation in bovine large penile arteries 82 and horse deep penile vein. 17 In horse penile small arteries, we first observed that the component of the endothelium-dependent relaxations resistant to NOS and cyclooxygenase blockade was inhibited by raising extracellular K þ and by a combination of intermediate-and small-conductance Ca 2 þ -activated K þ (K Ca ) channel blockers, thus suggesting the involvement of a hyperpolarizing factor. 61 These findings were further confirmed in human penile arteries, where the EDHF-mediated relaxations were enhanced by calcium dobesilate. 83 In horse penile arteries, the EDHF-type response is also markedly inhibited by ouabain, which suggests an involvement of the Na þ -K þ ATPase. 61 The identity of EDHF still remains controversial and there is probably more than one EDHF. 81 93 The available experimental evidence supports three explanations for the identity and actions of EDHF: (a) increased [Ca 2 þ ] i triggers the synthesis of a CP450 metabolite which is essential for the EDHFtype responses; (b) endothelial cell hyperpolarization is transmitted to the smooth muscle cell through myoendothelial gap junctions that couple both types of cells providing a low-resistance electrical pathway; (c) K þ ions released from endothelial cells through K Ca induce hyperpolarization of the adjacent smooth muscle cells by activating K þ channels and/or the Na þ -K þ ATPase. 81, 93 In penile small arteries, endothelial intermediateconductance K Ca channels have been shown to be involved in the release of a non-NO non-prostanoid factor in rat intracavernous arteries, 94 although the identity of EDHF remains to be clarified.
Whereas in CC there is a functional impairment of the NO-mediated endothelium-dependent responses in vascular diseases, such as hypertension, hypercholesterolemia and diabetes mellitus, 95, 96 recent investigations have shown that endothelial abnormalities also include reduced EDHF-type relaxations in penile small arteries from diabetic men and from a rat model of renal hypertension. 19, 84 Intracellular signaling pathways underlying penile vasodilatation The NO/cGMP pathway. NO released from nerve terminals or endothelium diffuses into adjacent vascular or trabecular smooth muscle cells and binds to its 'natural receptor', the enzyme guanylate cyclase to increase intracellular cGMP levels and the activity of the cGMP-dependent protein kinase G (PKG). 4, 8 cGMP-independent NO relaxant effects have been reported in both trabecular smooth muscle 97 and penile small arteries, 61 where this agent can stimulate the Na þ -K þ ATPase to induce hyperpolarization. However, the importance of the PKG-mediated relaxation in the erectile process has been shown in PKG-deficient mice that are unable to reproduce and have impaired relaxations in response to neural-and endothelial-derived NO. 99 In rat and human CC, NO and cGMP act synergistically to reduce Ca 2 þ release from the intracellular stores, 48 a mechanism that seems unlikely in penile arteries, where intracellular Ca 2 þ mobilization plays a minor role in vasoconstriction. 47 Activation of K þ channels is a powerful mechanism of vascular smooth muscle hyperpolarization and relaxation, and both cGMP and cAMP can modulate the activity of K þ channels to elicit vasodilatation. 99 ,100 K Ca channels are activated by intracellular Ca 2 þ and depolarization, and they are involved in the maintenance of resting tone and are downstream mediators of the NO/cGMP signaling cascade in both CC and penile resistance Physiological regulation of penile arteries and veins D Prieto arteries. 6, 59, 61, 101 Thus, the relaxations induced by NO and NO donors in horse penile resistance arteries are inhibited by charybdotoxin and iberiotoxin, and this inhibition is not further increased by blockers of PKG, thus suggesting that the relaxant effect of NO is due in part to activation of large conductance K Ca (BK Ca ) through a PKGdependent mechanism (Figure 2) . 59, 61, 101 In horse deep dorsal penile veins, voltage-dependent K þ channels are involved in the maintenance of basal tone and also in the cGMP-mediated NO-induced vasodilatation. 17 Phosphorylation and activation of MLCP by PKG can reduce Ca 2 þ sensitivity of the erectile tissue to elicit relaxation. Thus, in a-toxin permeabilized strips of human CC, stimulation of PKG with cGMP analogues reverses Ca 2 þ sensitization and contraction evoked by both non-selective and ET-induced activation of G-protein-coupled receptors. 52 In vascular myocytes, PKG phosphorylates and inhibits RhoA, which suggests that the consequent inhibition of RhoA-induced Ca 2 þ sensitization and actin cytoskeleton organization contributes to the vasodilator action of NO. 102 The fact that threshold concentrations of the RhoK inhibitor Y-27632 enhanced the NO-evoked increase in intracavernous pressure in a rat in vivo model has led to the suggestion that NO may inhibit RhoK-induced cavernosal vasoconstriction during erection. 103 Further studies are necessary to clarify whether a RhoA-regulated PKG-mediated reduction in Ca 2 þ sensitivity is also involved in the NO-induced vasodilatation of penile arteries and veins.
Classically, NO released from nerves and endothelium during erection acts on guanylate cyclase in penile smooth muscle cells to elicit relaxation. Interestingly, recent studies have shown that soluble guanylate cyclase and caveolin-1 are associated in the endothelial cells of the rat CC and that this compartmentalization contributes to the NO signaling pathway involved in smooth muscle relaxation and erection. 104 Cyclic nucleotide phosphodiesterases (PDEs) are a superfamily of hydrolytic enzymes that degrade cGMP and cAMP thereby terminating its biological actions. The cGMP-specific cGMP binding PDE5 is the main cGMP catalyzing enzyme in penile smooth muscle and a target for pharmacological intervention in the treatment of ED, since selective inhibitors of the enzyme are safe and well-tolerated drugs in the oral therapy of organic ED. 78, 105 Three isoforms of PDE5, PDE5 A2, PDE5 A1 and PDE5 A3 are expressed in the human CC, 106 and the human PDE5A gene promoter has been identified and shown to contain cGMP response elements that are stimulated upon cGMP binding, 107 which suggests that PDE inhibitors might up-regulate the synthesis of their own target.
PDE5 is abundant in the smooth muscle layer of human penile cavernous and helicine arteries, where the functional effects of the selective inhibitor sildenafil have been characterized. 68, 108, 109 In contrast to the CC, where sildenafil produces little or no relaxation but enhances the effects of neural-released NO, 110 sildenafil potently relaxed cavernous and helicine arteries. 68, 108, 109 This vasodilatation was endothelium-dependent and was blocked by inhibitors of NOS, guanylate cyclase and BK Ca channels, which suggests that by inhibiting cGMP breakdown sildenafil augments the relaxing effects of endothelial-derived NO. 101, 109 These observations are consistent with studies showing that sildenafil cannot normalize the impaired endothelium-dependent responses of human penile arteries in diabetic patients with ED 84 and could explain the lesser clinical efficacy of sildenafil in these patients, in whom endothelial NO availability is decreased.
84,90
The adenylate cyclase/cAMP pathway. b-Adrenoceptors, prostanoid receptors of the EP 2 -and EP 4 subtypes and VIP/pituitary adenylate cyclase activating polypeptide (VPAC) receptors are Gprotein-coupled receptors that activate adenylate cyclase and increase intracellular cAMP levels. cAMP-mediated relaxations of vascular smooth muscle primarily involve protein kinase A (PKA) activation and subsequent decreases in Ca 2 þ and/or Ca 2 þ sensitivity. 28, 29 In penile small arteries, PGE 1 relaxant responses are mediated by cAMP and activation of ATP-sensitive K þ channels (K ATP ) (Figure 2) , 75, 111 in contrast to CC where K Ca channels are involved. 112 The activity of cAMP is terminated by the cAMPspecific PDE4 and the cGMP-inhibited cAMP-specific PDE3. They have been localized in the smooth muscle layer of intracavernous and penile resistance arteries, and in the case of PDE4 also in the cytoplasm of endothelial cells lining the cavernous arteries. 108 Selective inhibition of PDE4 and PDE3 evoked potent relaxations in penile resistance arteries, which suggests an enhancement of the effects of basal cAMP production in the arterial wall; the fact that relaxations evoked by the selective PDE4 inhibitor rolipram are inhibited by cyclooxygenase blockade in turn indicates an involvement of PDE4 in the release and/or effects of relaxant prostanoids. 75 Accumulated evidence suggests a crosstalk between the cGMP and cAMP signaling pathways in the erectile tissues of the penis. Thus, in horse penile resistance arteries, cAMP elevating agents can activate PKG and BK Ca channels through a PKGdependent mechanism, thus interacting downstream with the NO/cGMP pathway. 75, 101 On the other hand, cGMP-elevating agents such as sildenafil or NO can activate PKA, probably by increasing cAMP levels through an inhibition of PDE3, as shown in human CC and cardiac tissue. 113 
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Conclusions
Studies during the past few years have revealed new aspects of the physiology of the penile vasculature showing notable differences in the mechanisms underlying vasodilatation/vasoconstriction between CC and penile arteries and veins. The role of Ca 2 þ in penile arterial vasoconstriction has recently been clarified, and both Ca 2 þ entry and Ca 2 þ sensitization mechanisms are involved. There is also a capacitative calcium entry not associated with the contractile function of the smooth muscle cell, and its role in gene expression and its relevance for cell proliferation and vascular remodeling should be investigated.
Concerning the endothelial physiology, the existence of an EDHF-type response in penile small arteries and its impairment in diabetes and hypertension, the link between neural-derived NO and endothelial NO production during penile erection through Akt phosphorylation of eNOS, and the endothelial NO dependence for the action of PDE5 inhibitors in penile arteries, have been demonstrated. However, important issues such as the identity of EDHF and its electrophysiological actions, as well as the mechanisms underlying the excitation-secretion coupling in the penile vascular endothelium with regard to the role of K þ channels, the RhoA/RhoK system and the NO/guanylate cyclase pathway remain to be clarified. These intracellular signaling pathways in both the endothelial and the smooth muscle cell are putative molecular targets for the development of new therapies for the treatment of ED. Their role in the impaired function associated to cardiovascular risk situations leading to ED should be investigated in the penile vasculature, since recent evidence suggests that arterial insufficiency precedes the structural and functional changes in CC leading to ED.
